Teva Pharmaceutical (TEVA) delivered a compelling performance in the third quarter, with financial results exceeding market expectations. The company reported quarterly revenue of $4.48 billion, a 3% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback